Blog

Archive for the ‘biotech/medical’ category: Page 2422

Jan 18, 2017

Royal Australian Air Force Using HoloLens to Experiment with Augmented Reality

Posted by in categories: augmented reality, biotech/medical, habitats, military

The limitless applications of 3D data visualization will enable a more efficient approach to many of life’s problems. Each day, developers exploring this technology are finding new ways to solve these problems in mixed reality; 3D modeling, easier house management, spinal surgery, and forest fire management are just a few recent examples of ways 3D data visualization can benefit us all.

The military, on the other hand, has quite a different set of problems to manage.

From a logistics standpoint, there are a lot of moving parts in the military to consider such as personnel, deployment, training, resources, and supply lines, to name just a few things that have to be managed constantly. Here we are talking big-picture ideas that could utilize 3D data visualization from a top-down view. If we scale down to real-time operations for individual missions, there’s recon, intel, tracking, and response, and this list could keep going.

Continue reading “Royal Australian Air Force Using HoloLens to Experiment with Augmented Reality” »

Jan 18, 2017

It was nothing less than amazing speaking to the Masters Degree Program of Orthotics and Prosthetics at Eastern Michigan University today

Posted by in categories: biotech/medical, cyborgs, transhumanism

I was able to demonstrate the Bebionic and its components while also hooking one of the students up to our small hand so they could get a taste of what it’s like to Bebionic. I also had the chance to demonstrate and speak on the importance of fitting patients with an ETD such as my Motion Control, Inc. from Fillauer to accompany the Bebion…ic hand.

We got to talk about the basic components of a myoelectric prosthesis as well as some of the advanced systems such as the Coapt Direct Control and Morph system from Infinite Biomedical Technologies, LLC. With all of the major advances in upper limb prosthetics in recent times it’s great to be part of this technology.

A big thanks to Wendy the program director and faculty for having me visit your program and for making me feel welcome. You have an amazing facility. I will be looking forward to revisiting the program this fall. Steeper Group Steeper USA.

Continue reading “It was nothing less than amazing speaking to the Masters Degree Program of Orthotics and Prosthetics at Eastern Michigan University today” »

Jan 17, 2017

Human organs-on-chips: Harvard develops microchips lined with living cells to revolutionise medicine

Posted by in categories: biotech/medical, computing, engineering, neuroscience

Biological engineers at Harvard University’s Wyss Institute for Biologically Inspired Engineering have invented a microchip that can be lined with living human cells in order to revolutionise medicine, particularly relating to drug testing, disease modelling and personalised medicine.

The ‘human organs-on-chip’ is a microchip made from a clear flexible polymer that contains hollow microfluidic channels that are lined with living human cells, together with an interface that lines the interior surface of blood vessels and lymphatic vessels, known as an endothelium.

The idea is that the microchip can emulate the microarchitecture and functions of multiple human organs such as the lungs, kidneys, skin, bone marrow, intestines and blood-brain barrier. And if you were able to do this, you could then test out drugs and study how diseases affect the body without having to endanger human patients, or waste precious organs needed for transplants.

Continue reading “Human organs-on-chips: Harvard develops microchips lined with living cells to revolutionise medicine” »

Jan 17, 2017

Even a Little Daily Activity May Boost Colon Cancer Survival: Study

Posted by in categories: biotech/medical, health

Interesting.


TUESDAY, Jan. 17, 2017 (HealthDay News) — Just a half hour a day of moderate physical activity could be potent medicine for patients with advanced colon cancer, preliminary research suggests.

Study authors who tracked more than 1,200 colon cancer patients found a 19 percent decline in risk for early death among those who got 30 minutes or more of moderate exercise daily.

Continue reading “Even a Little Daily Activity May Boost Colon Cancer Survival: Study” »

Jan 17, 2017

Epigenetics Drives Pancreatic Cancer Metastasis, Potentially Reversible

Posted by in categories: bioengineering, biotech/medical, genetics

Epigenetic changes, not DNA mutations, drive some metastasis.

Read more

Jan 17, 2017

Malaria Drug Successfully Treats 26 Year Old Brain Cancer Patient

Posted by in categories: biotech/medical, neuroscience

Summary: Researchers report an anti malaria drug has helped improve length and quality of life for a 26 year old brain cancer patient.

Source: University of Colorado.

Continue reading “Malaria Drug Successfully Treats 26 Year Old Brain Cancer Patient” »

Jan 17, 2017

Cancer agency hacked for data won’t pay ransom

Posted by in categories: biotech/medical, bitcoin, computing

Pathetic. This is truly a new low for Ransomware hackers.


MUNCIE — An Indiana cancer services agency says it will replace and rebuild its data after a computer hack demanding a ransom.

Cancer Services of East Central Indiana-Little Red Door in Muncie says it was hacked Jan. 11 and the hackers demanded a ransom of 50 bitcoins, or about $43,000, for access to its data.

Continue reading “Cancer agency hacked for data won’t pay ransom” »

Jan 17, 2017

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Posted by in categories: biotech/medical, genetics

Nice.


Researchers from the Genes and Cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) have identified inactivating mutations in a number of genes that code for HLA-I histocompatibility complex proteins, which are involved in the immune response and can condition the response of lung cancer patients to immunotherapy. The study is a result of the collaboration between several national and international research centers, and has been published in the journal Clinical Cancer Research.

“Initially, we performed a genetic screening of lung cancer tumors using xenograft models, that is, human tumors that grow in mice, to obtain tumors with a low load of normal human cells,” explains Dr. Montse Sanchez-Cespedes, the last author of the paper. Sequencing of the tumors made it possible to identify several mutated genes, including some oncogenes and known tumor suppressor genes, and others that not previously described. “Among the latter, we were particularly interested in the B2M gene for its involvement in the functioning of the immune system, a target of new therapies developed for this type of cancer.”

Continue reading “Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows” »

Jan 17, 2017

Superbugs now killing more Americans than breast cancer… the scourge of antibiotics continues

Posted by in categories: biotech/medical, health

Antibiotic-resistant superbugs are now killing more people than breast cancer, according to a new data analysis by the UK Sepsis Trust.

According to the British Department of Health, about 5,000 people die each year from drug-resistant infections. But the UK Sepsis Trust and others have criticized these figures for being based on studies conducted in other countries, many of them with flawed methodology.

For the new analysis, the UK Sepsis Trust looked at the Department of Health’s own data to come up with an estimate of 12,000 killed per year by superbugs — more than twice as high as the current estimate.

Continue reading “Superbugs now killing more Americans than breast cancer… the scourge of antibiotics continues” »

Jan 17, 2017

Inactive B2M gene is recurrent in lung cancer and may condition response to immunotherapy

Posted by in categories: biotech/medical, genetics

Big deal.


Researchers from the Genes and Cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) have identified inactivating mutations in a number of genes that code for HLA-I histocompatibility complex proteins, which are involved in the immune response and can condition the tesponse of lung cancer patients to immunotherapy. The study is a result of the collaboration between several national and international research centers, and has been published in the journal Clinical Cancer Research.

“Initially, we performed a genetic screening of lung cancer tumors using xenograft models, that is, human tumors that grow in mice, to obtain tumors with a low load of normal human cells,” explains Dr. Montse Sanchez-Cespedes, the last author of the paper. Sequencing of the tumors made it possible to identify several mutated genes, including some oncogenes and known tumor suppressor genes, and others that not previously described. “Among the latter, we were particularly interested in the B2M gene for its involvement in the functioning of the immune system, a target of new therapies developed for this type of cancer.”

Continue reading “Inactive B2M gene is recurrent in lung cancer and may condition response to immunotherapy” »